Adaptin Bio, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
Adaptin Bio, Inc. (APTN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of 1.80% for the 12-month period ending 2024-12-31, per its S-1 filed 2026-08-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2026-08-28
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month |
|---|---|
| 2024-12-31 | 1.80% S-1 · filed 2026-08-28 |